Indeed, the antitumor effects of the combination of phenformin with PLX4720, a BRAF inhibitor, on the proliferation of BRAF-mutated melanoma both in vitro and on tumor growth promoted by BRAF in vivo have been investigated. This evidence concerns the gene BRAF and neoplasm.